FDA committee rejects oxycodegol, new opioid designed for less abuseJanuary 14, 2020PainMental HealthNeurology
In addiction, abusive partners can wreak havocDecember 9, 2019Opioid Resource CenterAddiction MedicineMental HealthPain
Addiction specialists: Cannabis policies should go up in smokeDecember 9, 2019Addiction MedicineNeurologyMental HealthPain
Survey: Cancer-related pain, opioid use up since 2018November 25, 2019OncologyOpioid Resource CenterPainHematology
OA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factorsNovember 24, 2019RheumatologyPain
Elagolix is effective second-tier treatment for endometriosis-associated dysmenorrheaNovember 22, 2019Women's HealthPainEndocrinology
FDA announces approval of fifth adalimumab biosimilar, AbriladaNovember 18, 2019GastroenterologyDermatologyRheumatologyPain
Support for medical marijuana transcends political affiliationNovember 15, 2019OncologyPainAddiction Medicine
Opioid reduction works after minimally invasive gynecologic surgeryNovember 14, 2019Opioid Resource CenterWomen's HealthPainPreventive CareAddiction Medicine
CBD: What physicians need to know about itOctober 28, 2019PainMental HealthNeurologyMusculoskeletal DisordersAddiction Medicine